Alembic Pharma Head of International Business Formulations Prashant Khandelwal resigns

Written By :  Ruchika Sharma
Published On 2025-12-01 10:00 GMT   |   Update On 2025-12-01 10:00 GMT
Advertisement

Vadodara: Alembic Pharma has announced that Prashant Khandelwal, Head-International Business Formulations, has resigned from his position. He will be relieved from his role effective December 1, 2025, after closure of business hours.

Khandelwal has over two decades of experience in pharmaceutical marketing & selling of formulations (OSD, injectables, topicals) in various countries in Latin America, CIS (including Russia), ASEAN, Australia & Africa.

Advertisement

He has proven experience in aligning team members across different geographies and departments to deliver high productivity with clearly defined objectives and rewards. 

Before joining AlembicKhandelwal worked at Dr Reddy's Labs in various roles. He also served at Strides Acrolab, and Ranbaxy.

Read also: Alembic Pharma gets USFDA okay for Sumatriptan Injection, Single Dose Autoinjector System

Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. It is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.

Read also: Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed Release

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News